- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Managed Healthcare Executive: All 12 of Our 2022 Cover Stories
A one-stop-shop for 2022 cover stories.
December 2022
December: Beyond the Big Three PBMs
Smaller and midsize pharmacy benefit managers are taking on Optum Rx, CVS Caremark and Express Scripts. They say they have better technology and are more transparent about their pricing.
November 2022
November: Medication Adherence
Our in-depth look at one of the forever-problems of healthcare: How to get people to take their medication as prescribed. The answers are increasingly bespoke.
October 2022
October: Primary Care in Critical Condition
Its physicians are overworked, and patients are going elsewhere for care. Experts say help is on its way for primary care in the United States — but so is an onslaught of new demands.
September 2022
September: 10 Emerging Health Leaders
Our annual list of outstanding individuals in healthcare in the early part of their careers.
August 2022
August: Our Annual Pharmacy Survey
Our annual survey about drugs and their costs had 950 respondents this year. We asked about theCOVID-19 pandemic, biosimilars, HIV PrEP, Wegovy and Aduhelm.
July 2022
July: Reforming Hospice
Some experts want to see more funding for hospice care in the home. Others say the advantages of hospice in a hospital or nursing home have been underrated.
June 2022
June: Medicaid Managed Care Plans Coming Under Scrutiny
States looked to Medicaid managed care plans to control costs and provide some predictability. Now a growing number are asking questions of the plans and investigating whether the plans are living up to their state contracts. Meanwhile, new federal reporting requirements are being implemented that may shed some light on how the plans operate.
May 2022
May: Heading Upstream to the Social Determinants of Health
There’s a long history to recognizing that social factors shape people’s health. But the social determinants of health are getting more attention than ever. Will that attention turn into action and lasting change?
April 2022
April: Finding a Way Forward for Public Health: Greater Investment, Greater Distrust
Infectious diseases have come roaring back as threat to health and well-being. But COVID-19 revealed the shortcomings of our public health systems. Research has linked loss of trust in government with lower vaccination. So how can that trust be restored?
March 2022
March: A Dangerous Pairing: COVID-19 and Obesity
People with obesity are already at heightened risk for a number of serious illnesses: diabetes, heart disease, some cancers. Severe COVID-19 can now be added to that list.
February 2022
February: Is Healthcare Ready For Blockchain?
Blockchain technology, the backbone of crytocucould soon be a very important part of the healthcare industry. Blockchain isa novel type of data-storage architecture with many potential applications.
January: State of the Industry Survey
January 2022
Our annual survey about readers’ attitudes and beliefs about developments in healthcare.
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
